BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17412697)

  • 1. Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor.
    Ishima R; Torchia DA; Louis JM
    J Biol Chem; 2007 Jun; 282(23):17190-9. PubMed ID: 17412697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.
    Sayer JM; Liu F; Ishima R; Weber IT; Louis JM
    J Biol Chem; 2008 May; 283(19):13459-70. PubMed ID: 18281688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor.
    Sayer JM; Aniana A; Louis JM
    J Mol Biol; 2012 Sep; 422(2):230-44. PubMed ID: 22659320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease.
    Louis JM; Ishima R; Aniana A; Sayer JM
    Protein Sci; 2009 Dec; 18(12):2442-53. PubMed ID: 19798742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
    Wondrak EM; Louis JM
    Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folded monomer of HIV-1 protease.
    Ishima R; Ghirlando R; Tözsér J; Gronenborn AM; Torchia DA; Louis JM
    J Biol Chem; 2001 Dec; 276(52):49110-6. PubMed ID: 11598128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM; Clore GM; Gronenborn AM
    Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
    Agniswamy J; Sayer JM; Weber IT; Louis JM
    Biochemistry; 2012 Feb; 51(5):1041-50. PubMed ID: 22242794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding regulates autoprocessing of HIV-1 protease precursor.
    Chatterjee A; Mridula P; Mishra RK; Mittal R; Hosur RV
    J Biol Chem; 2005 Mar; 280(12):11369-78. PubMed ID: 15632156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor.
    Ishima R; Torchia DA; Lynch SM; Gronenborn AM; Louis JM
    J Biol Chem; 2003 Oct; 278(44):43311-9. PubMed ID: 12933791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.
    Louis JM; Tözsér J; Roche J; Matúz K; Aniana A; Sayer JM
    Biochemistry; 2013 Oct; 52(43):7678-88. PubMed ID: 24079831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between protease and reverse transcriptase dimerization in a model HIV-1 polyprotein.
    Chagas BCA; Zhou X; Guerrero M; Ilina TV; Ishima R
    Protein Sci; 2024 Jul; 33(7):e5080. PubMed ID: 38896002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism.
    Louis JM; Wondrak EM; Kimmel AR; Wingfield PT; Nashed NT
    J Biol Chem; 1999 Aug; 274(33):23437-42. PubMed ID: 10438521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.
    Hayashi H; Takamune N; Nirasawa T; Aoki M; Morishita Y; Das D; Koh Y; Ghosh AK; Misumi S; Mitsuya H
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12234-9. PubMed ID: 25092296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The L76V drug resistance mutation decreases the dimer stability and rate of autoprocessing of HIV-1 protease by reducing internal hydrophobic contacts.
    Louis JM; Zhang Y; Sayer JM; Wang YF; Harrison RW; Weber IT
    Biochemistry; 2011 May; 50(21):4786-95. PubMed ID: 21446746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.
    Tang C; Louis JM; Aniana A; Suh JY; Clore GM
    Nature; 2008 Oct; 455(7213):693-6. PubMed ID: 18833280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
    Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
    Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
    Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C
    PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation.
    Wondrak EM; Nashed NT; Haber MT; Jerina DM; Louis JM
    J Biol Chem; 1996 Feb; 271(8):4477-81. PubMed ID: 8626801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.